BAG3 and breast carcinoma: Consistent with the findings of Das et al., an earlier study by Pasilass et al. applied a quantitative proteomic approach in the context of therapy-induced senescence to discover that BAG3 is upregulated after adriamycin treatment in MCF7 breast cancer cells.